about
Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosisMarginal structural Cox models for estimating the association between β-interferon exposure and disease progression in a multiple sclerosis cohortBeta-interferon exposure and onset of secondary progressive multiple sclerosis.Estimating inverse probability weights using super learner when weight-model specification is unknown in a marginal structural Cox model context.Determinants of Antibiotic Tailoring in Pediatric Intensive Care: A National Survey.Comparison of Statistical Approaches for Dealing With Immortal Time Bias in Drug Effectiveness Studies.Multiple sclerosis in older adults: the clinical profile and impact of interferon Beta treatmentInvestigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study.Can joint replacement reduce cardiovascular risk?Can We Train Machine Learning Methods to Outperform the High-dimensional Propensity Score Algorithm?Interferon beta and long-term disability in multiple sclerosis.THE AUTHORS REPLY.On the application of statistical learning approaches to construct inverse probability weights in marginal structural Cox models: Hedging against weight-model misspecificationHypothesis Testing for an Exposure–Disease Association in Case–Control Studies Under Nondifferential Exposure Misclassification in the Presence of Validation Data: Bayesian and Frequentist AdjustmentsAntibody dissociation rates are predictive of neutralizing antibody (NAb) course: A comparison of interferon beta-1b-treated Multiple Sclerosis (MS) patients with transient versus sustained NAbsDirected Acyclic Graphs to Identify ConfoundersAuthors' reply: Letter to the Editor: Regarding Karim et al. (SMMR, Vol 27, Issue 6, 2018)Multimorbidity prevalence in Canada: a comparison of Northern Territories with Provinces, 2013/14Nurses "Seeing Forest for the Trees" in the Age of Machine Learning: Using Nursing Knowledge to Improve Relevance and PerformanceRole of Nonsteroidal Antiinflammatory Drugs in the Association Between Osteoarthritis and Cardiovascular Diseases: A Longitudinal StudyA pragmatic randomized controlled trial testing the effects of the international scientific SCI exercise guidelines on SCI chronic pain: protocol for the EPIC-SCI trialReply
P50
Q28271140-7DBD0500-FB9A-49B6-AA90-656231152801Q33847487-DC141108-9D1B-4CA7-A34F-67A36DD37FC6Q37225075-553E9ADF-8F72-4B30-89F0-61F756DABFA9Q38951608-437FAD39-51BB-4D09-A7DD-34EBB833F17BQ39404986-22B5C73D-5511-4D25-8861-80BDF08D8469Q39562024-B7B9E907-1A3C-406F-9E46-7012D5CB3E20Q39646135-130DF223-4CC1-40B9-B6D3-E20CEAD52E40Q45108872-57101C8A-F916-40F1-A900-856DA9DABA8CQ45289280-2A95AAEE-6937-494C-956A-DDD7A3B2161CQ45943675-AC4C6ACD-4B1E-4BC1-990C-A4428AE868CDQ46463726-17C0CF07-FD0D-4059-9BCB-962A4CFFB3B2Q52114148-00380C80-30A8-4966-8C9A-A84363A04969Q57088363-C408AD5F-F1E9-437A-93E1-FEB07A1B1D95Q57088365-BE551BEE-0042-4094-8C98-CF60C136E5DAQ57088368-0B1C7B69-45DC-4EF5-B39A-8D168EB1C9F0Q57088370-E7EC1B95-D638-4092-99E4-604A442EF2ABQ58612479-0E2DCA47-C333-4989-B3F0-456888025969Q64075374-2B5C3D8A-BED2-4B86-A921-9E5E1794E8EFQ64117617-CAED1482-77A9-4D0F-B59C-9B9FF8191EE6Q92467820-7198C2EF-A6C1-4610-B958-4861CC850B95Q94687218-92216D7B-E0D9-4FC1-BBD9-6C47FE65BFE1Q96016593-E89F3B6C-E75A-401A-AE6C-AD91F587D6EC
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mohammad Ehsanul Karim
@ast
Mohammad Ehsanul Karim
@en
Mohammad Ehsanul Karim
@es
Mohammad Ehsanul Karim
@nl
type
label
Mohammad Ehsanul Karim
@ast
Mohammad Ehsanul Karim
@en
Mohammad Ehsanul Karim
@es
Mohammad Ehsanul Karim
@nl
altLabel
Ehsan Karim
@en
prefLabel
Mohammad Ehsanul Karim
@ast
Mohammad Ehsanul Karim
@en
Mohammad Ehsanul Karim
@es
Mohammad Ehsanul Karim
@nl
P1053
I-1803-2018
P106
P1153
55314538800
P2798
P31
P3829
P496
0000-0002-0346-2871